ELI LILLY & Co — Director's Dealing 2021

Feb 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2021-02-08

Reporting Person: Norton Johna (Senior VP, Global Quality)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-08	Common Stock	A	6040	$205.77	Acquired	25464	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-08	Restricted Stock Unit	$	A	2676	Acquired	2022-02-01	Common Stock (2676.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	507	Indirect
Common Stock	128	Indirect
Common Stock	2638	Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.

F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.